id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT02506192 | 16:26:treatment,30:45:treatment,37:45:treatment,58:65:treatment | Chronic use of Prednisone or Corticosteroids (occasional inhaled use of steroids acceptable) | 2 | [
"Chronic",
"use",
"of",
"Prednisone",
"or",
"Corticosteroids",
"(",
"occasional",
"inhaled",
"use",
"of",
"steroids",
"acceptable",
")"
] | [
0,
0,
0,
1,
0,
1,
0,
0,
1,
0,
0,
1,
0,
0
] |
NCT03179163 | 22:72:allergy_name | contraindication for all three pharmacotherapy drugs used in this study | 2 | [
"contraindication",
"for",
"all",
"three",
"pharmacotherapy",
"drugs",
"used",
"in",
"this",
"study"
] | [
0,
0,
4,
4,
4,
4,
4,
4,
4,
4
] |
NCT02332928 | 1:38:chronic_disease | chronic obstructive pulmonary disease requiring oxygen replacement | 2 | [
"chronic",
"obstructive",
"pulmonary",
"disease",
"requiring",
"oxygen",
"replacement"
] | [
2,
2,
2,
2,
0,
0,
0
] |
NCT01389024 | 1:35:treatment,39:50:treatment,,82:91:treatment | Treatment with anti-sickling drugs or hydroxyurea within 3 months or anticipated treatment during the course of the study | 2 | [
"Treatment",
"with",
"anti-sickling",
"drugs",
"or",
"hydroxyurea",
"within",
"3",
"months",
"or",
"anticipated",
"treatment",
"during",
"the",
"course",
"of",
"the",
"study"
] | [
1,
1,
1,
1,
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02573883 | 1:17:chronic_disease,8:17:chronic_disease,19:26:chronic_disease,28:34:chronic_disease,36:55:chronic_disease,57:71:chronic_disease | vulvar infection (candida, herpes, bacterial vaginosis, trichomoniasis or other infection) | 2 | [
"vulvar",
"infection",
"(",
"candida",
",",
"herpes",
",",
"bacterial",
"vaginosis",
",",
"trichomoniasis",
"or",
"other",
"infection",
")"
] | [
2,
2,
0,
2,
0,
2,
0,
2,
2,
0,
2,
0,
0,
0,
0
] |
NCT02518594 | 19:41:treatment,, | Planned or actual progesterone treatment of any type or form after 14 weeks 6 days during the current pregnancy | 2 | [
"Planned",
"or",
"actual",
"progesterone",
"treatment",
"of",
"any",
"type",
"or",
"form",
"after",
"14",
"weeks",
"6",
"days",
"during",
"the",
"current",
"pregnancy"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01187368 | 34:47:chronic_disease, | Presence of condition other than heart failure that would limit survival to less than 3 years | 2 | [
"Presence",
"of",
"condition",
"other",
"than",
"heart",
"failure",
"that",
"would",
"limit",
"survival",
"to",
"less",
"than",
"3",
"years"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02926378 | 10:19:treatment,21:34:treatment,55:68:treatment | having a pacemaker, defibrillator or wires other than sternal wires | 2 | [
"having",
"a",
"pacemaker",
",",
"defibrillator",
"or",
"wires",
"other",
"than",
"sternal",
"wires"
] | [
0,
0,
1,
0,
1,
0,
0,
0,
0,
1,
1
] |
NCT02468778 | 5:37:treatment, | Any prior coronary revascularization within the last 6 months | 2 | [
"Any",
"prior",
"coronary",
"revascularization",
"within",
"the",
"last",
"6",
"months"
] | [
0,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02452268 | 1:22:treatment,26:43:treatment,45:58:treatment,60:72:treatment,74:87:treatment,89:107:treatment,111:132:treatment,,191:202:treatment,206:220:treatment,224:236:treatment,240:251:treatment, | Prior IL-15 treatment or cytotoxic therapy, immunotherapy, radiotherapy, major surgery, antitumor vaccines or monoclonal antibodies in the 4 weeks prior or for checkpoint inhibitors such as anti-CTLA-4 or anti PD1/PD-L1 or nitrosoureas or mitomycin C for 6 weeks prior to C1D1 | 2 | [
"Prior",
"IL-15",
"treatment",
"or",
"cytotoxic",
"therapy",
",",
"immunotherapy",
",",
"radiotherapy",
",",
"major",
"surgery",
",",
"antitumor",
"vaccines",
"or",
"monoclonal",
"antibodies",
"in",
"the",
"4",
"weeks",
"prior",
"or",
"for",
"checkpoint",
"inhib... | [
1,
1,
1,
0,
1,
1,
0,
1,
0,
1,
0,
1,
1,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02624258 | ,,81:98:chronic_disease, | Must have a minimum level of pulmonary reserve defined as ≤ Grade 1 dyspnea and pulse oxygenation > 94% on room air | 2 | [
"Must",
"have",
"a",
"minimum",
"level",
"of",
"pulmonary",
"reserve",
"defined",
"as",
"≤",
"Grade",
"1",
"dyspnea",
"and",
"pulse",
"oxygenation",
">",
"94",
"%",
"on",
"room",
"air"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT03008616 | 1:23:chronic_disease | Active hepatic disease | 2 | [
"Active",
"hepatic",
"disease"
] | [
2,
2,
2
] |
NCT01072370 | 19:38:chronic_disease | Presence of known chromosomal anomaly | 2 | [
"Presence",
"of",
"known",
"chromosomal",
"anomaly"
] | [
0,
0,
0,
2,
2
] |
NCT02389517 | 12:37:chronic_disease,46:78:chronic_disease,89:123:chronic_disease | Ongoing or active systemic infection, active hepatitis B or C virus infection, or known human immunodeficiency virus (HIV) positive | 2 | [
"Ongoing",
"or",
"active",
"systemic",
"infection",
",",
"active",
"hepatitis",
"B",
"or",
"C",
"virus",
"infection",
",",
"or",
"known",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"positive"
] | [
0,
0,
2,
2,
2,
0,
0,
2,
2,
2,
2,
2,
2,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0
] |
NCT01738009 | 1:15:chronic_disease | Claustrophobia | 2 | [
"Claustrophobia"
] | [
2
] |
NCT02166905 | 13:31:treatment,91:106:treatment,108:122:treatment,126:163:treatment,169:201:treatment | Concomitant systemic treatment with chronic use (based on the investigator's judgment) of corticosteroids, anti-histamine or non-steroidal anti-inflammatory drugs, and other platelet inhibitory agents | 2 | [
"Concomitant",
"systemic",
"treatment",
"with",
"chronic",
"use",
"(",
"based",
"on",
"the",
"investigator",
"'s",
"judgment",
")",
"of",
"corticosteroids",
",",
"anti-histamine",
"or",
"non-steroidal",
"anti-inflammatory",
"drugs",
",",
"and",
"other",
"platelet",
... | [
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
1,
1,
0,
0,
1,
1,
1,
1
] |
NCT02236000 | 1:14:cancer, | Breast cancer must be determined by local testing to be human epidermal growth factor receptor 2 (HER2)-positive prior to study entry using American Society of Clinical Oncology (ASCO) - College of American Pathologists (CAP) HER2 test guidelines | 2 | [
"Breast",
"cancer",
"must",
"be",
"determined",
"by",
"local",
"testing",
"to",
"be",
"human",
"epidermal",
"growth",
"factor",
"receptor",
"2",
"(",
"HER2",
")",
"-positive",
"prior",
"to",
"study",
"entry",
"using",
"American",
"Society",
"of",
"Clinical",
... | [
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02987491 | 1:21:chronic_disease,, | Hypercholesterolemia (fasting LDL>140mg/dl) | 2 | [
"Hypercholesterolemia",
"(",
"fasting",
"LDL",
">",
"140mg/dl",
")"
] | [
2,
0,
0,
0,
0,
0,
0
] |
NCT02721303 | 1:15:chronic_disease | Claustrophobia | 2 | [
"Claustrophobia"
] | [
2
] |
NCT02143726 | 21:85:treatment | Chronic concomitant treatment with strong inhibitors of cytochrome P450 3A4 (CYP3A4) | 2 | [
"Chronic",
"concomitant",
"treatment",
"with",
"strong",
"inhibitors",
"of",
"cytochrome",
"P450",
"3A4",
"(",
"CYP3A4",
")"
] | [
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0
] |
NCT02567422 | 38:60:treatment | Patients who are receiving any other investigational agents | 2 | [
"Patients",
"who",
"are",
"receiving",
"any",
"other",
"investigational",
"agents"
] | [
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02585973 | 1:20:chronic_disease | HPV/p16 (+) disease | 2 | [
"HPV/p16",
"(",
"+",
")",
"disease"
] | [
2,
2,
2,
0,
0
] |
NCT02577367 | 31:42:treatment,87:101:treatment,103:113:treatment,115:125:treatment,127:134:treatment,136:144:treatment,146:156:treatment,161:169:treatment | Concomitant administration of medications that affect thyroid function test including Cholestyramine, Sucralfate, Amiodarone, Lithium, Dopamine, Dobutamine and Dilantin at enrollment | 2 | [
"Concomitant",
"administration",
"of",
"medications",
"that",
"affect",
"thyroid",
"function",
"test",
"including",
"Cholestyramine",
",",
"Sucralfate",
",",
"Amiodarone",
",",
"Lithium",
",",
"Dopamine",
",",
"Dobutamine",
"and",
"Dilantin",
"at",
"enrollment"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0
] |
NCT01555905 | 19:40:chronic_disease | No diagnosis of a neuromusuclar disease | 2 | [
"No",
"diagnosis",
"of",
"a",
"neuromusuclar",
"disease"
] | [
0,
0,
0,
0,
2,
2
] |
NCT02937402 | 50:82:chronic_disease | Inability to perform informed consent due to any medical or psychiatric condition | 2 | [
"Inability",
"to",
"perform",
"informed",
"consent",
"due",
"to",
"any",
"medical",
"or",
"psychiatric",
"condition"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2
] |
NCT03023449 | ,43:49:chronic_disease | Study can be initiated within 72 hours of stroke symptom onset | 2 | [
"Study",
"can",
"be",
"initiated",
"within",
"72",
"hours",
"of",
"stroke",
"symptom",
"onset"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0
] |
NCT02373644 | 1:19:treatment | Sacral compression | 2 | [
"Sacral",
"compression"
] | [
1,
1
] |
NCT01758042 | 21:28:treatment,83:90:allergy_name,94:113:allergy_name | Contraindication to therapy with any one of the proposed agents (e.g., history of allergy to rabbit serum in ATG) | 2 | [
"Contraindication",
"to",
"therapy",
"with",
"any",
"one",
"of",
"the",
"proposed",
"agents",
"(",
"e.g.",
",",
"history",
"of",
"allergy",
"to",
"rabbit",
"serum",
"in",
"ATG",
")"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
4,
4,
4,
4,
0
] |
NCT01835626 | ,89:99:treatment | agreement not to donate sperm during the study and for 3 months after the final dose of vismodegib | 2 | [
"agreement",
"not",
"to",
"donate",
"sperm",
"during",
"the",
"study",
"and",
"for",
"3",
"months",
"after",
"the",
"final",
"dose",
"of",
"vismodegib"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02460900 | 15:26:treatment, | Recent use of Varenicline (by participant report in the past 3 months) | 2 | [
"Recent",
"use",
"of",
"Varenicline",
"(",
"by",
"participant",
"report",
"in",
"the",
"past",
"3",
"months",
")"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02406599 | 49:55:cancer | Multi-centric disease (histologically diagnosed cancer in two different quadrants of the breast) | 2 | [
"Multi-centric",
"disease",
"(",
"histologically",
"diagnosed",
"cancer",
"in",
"two",
"different",
"quadrants",
"of",
"the",
"breast",
")"
] | [
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03105362 | 8:21:treatment | Stable GI medication regime | 2 | [
"Stable",
"GI",
"medication",
"regime"
] | [
0,
1,
1,
0
] |
NCT02875301 | 7:27:chronic_disease | other cardiovascular event | 2 | [
"other",
"cardiovascular",
"event"
] | [
0,
2,
2
] |
NCT02547818 | 24:35:treatment, | Stability of permitted medications for 4 weeks prior to study start | 2 | [
"Stability",
"of",
"permitted",
"medications",
"for",
"4",
"weeks",
"prior",
"to",
"study",
"start"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01241708 | 1:13:treatment,17:29:treatment,,58:67:treatment | Chemotherapy or radiotherapy within 8 days of initiating treatment in this study | 2 | [
"Chemotherapy",
"or",
"radiotherapy",
"within",
"8",
"days",
"of",
"initiating",
"treatment",
"in",
"this",
"study"
] | [
1,
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT01836354 | 1:4:chronic_disease | TIA based on a clinical definition of focal neurologic deficits consistent with a single vascular territory of the brain | 2 | [
"TIA",
"based",
"on",
"a",
"clinical",
"definition",
"of",
"focal",
"neurologic",
"deficits",
"consistent",
"with",
"a",
"single",
"vascular",
"territory",
"of",
"the",
"brain"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02076906 | 1:20:cancer | Lesion in the skull | 2 | [
"Lesion",
"in",
"the",
"skull"
] | [
3,
3,
3,
3
] |
NCT02159027 | 14:30:chronic_disease | Uncontrolled seizure disorder | 2 | [
"Uncontrolled",
"seizure",
"disorder"
] | [
0,
2,
2
] |
NCT02966665 | 12:51:treatment | History of percutaneous coronary revascularization | 2 | [
"History",
"of",
"percutaneous",
"coronary",
"revascularization"
] | [
0,
0,
1,
1,
1
] |
NCT02203513 | 46:52:cancer,60:70:cancer,74:101:cancer,103:128:cancer,137:158:cancer | For Cohorts 1-3, 5 and 6: patients must have breast and/or epithelial or endometrioid ovarian cancer, primary peritoneal cancer, and/or fallopian tube cancer histologically or cytologically confirmed at the NCI that is metastatic or unresectable and for which standard curative measures do not exist or are no longer eff... | 2 | [
"For",
"Cohorts",
"1-3",
",",
"5",
"and",
"6",
":",
"patients",
"must",
"have",
"breast",
"and/or",
"epithelial",
"or",
"endometrioid",
"ovarian",
"cancer",
",",
"primary",
"peritoneal",
"cancer",
",",
"and/or",
"fallopian",
"tube",
"cancer",
"histologically",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
0,
3,
3,
3,
0,
3,
3,
3,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03112902 | 1:49:chronic_disease | rapid eye movement (REM)-sleep behavior disorder | 2 | [
"rapid",
"eye",
"movement",
"(",
"REM",
")",
"-sleep",
"behavior",
"disorder"
] | [
2,
2,
2,
2,
2,
2,
0,
0,
0
] |
NCT02531932 | 1:40:chronic_disease,44:68:chronic_disease,116:126:treatment,134:152:chronic_disease,185:193:chronic_disease,195:217:chronic_disease,221:242:treatment | Impairment of gastrointestinal function or gastrointestinal disease that may significantly alter the absorption of Everolimus (e.g., ulcerative disease, uncontrolled nausea, vomiting, diarrhea, malabsorption syndrome or small bowel resection) | 2 | [
"Impairment",
"of",
"gastrointestinal",
"function",
"or",
"gastrointestinal",
"disease",
"that",
"may",
"significantly",
"alter",
"the",
"absorption",
"of",
"Everolimus",
"(",
"e.g.",
",",
"ulcerative",
"disease",
",",
"uncontrolled",
"nausea",
",",
"vomiting",
",",... | [
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
1,
1,
1,
0
] |
NCT03006770 | 1:31:treatment | endovascular revascularization | 2 | [
"endovascular",
"revascularization"
] | [
1,
1
] |
NCT02826577 | 12:32:chronic_disease | History of heart irregularities | 2 | [
"History",
"of",
"heart",
"irregularities"
] | [
0,
0,
2,
2
] |
NCT02582827 | 12:31:chronic_disease | History of vascular neuropathy | 2 | [
"History",
"of",
"vascular",
"neuropathy"
] | [
0,
0,
2,
2
] |
NCT01562626 | ,104:109:cancer,150:167:treatment,202:204:treatment,208:218:treatment,226:244:treatment | Patients enrolled at Dose Level 6 or higher in the phase I portion of the trial must have at least one tumor mass suitable and easily accessible for excisional biopsy, or alternatively, accessible for CT or ultrasound guided core needle biopsy | 2 | [
"Patients",
"enrolled",
"at",
"Dose",
"Level",
"6",
"or",
"higher",
"in",
"the",
"phase",
"I",
"portion",
"of",
"the",
"trial",
"must",
"have",
"at",
"least",
"one",
"tumor",
"mass",
"suitable",
"and",
"easily",
"accessible",
"for",
"excisional",
"biopsy",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
1,
1
] |
NCT02620761 | 25:37:treatment | No previous exposure to indomethacin | 2 | [
"No",
"previous",
"exposure",
"to",
"indomethacin"
] | [
0,
0,
0,
0,
1
] |
NCT02245841 | 1:31:chronic_disease | amyopathic dermatomyositis(AD) | 2 | [
"amyopathic",
"dermatomyositis",
"(",
"AD",
")"
] | [
2,
2,
0,
0,
0
] |
NCT01959425 | 1:18:chronic_disease,27:56:chronic_disease,58:70:chronic_disease,74:78:chronic_disease | pulmonary disease, (e.g., restrictive pulmonary disease, constrictive or COPD) or any other disease or malfunction of the lungs or respiratory system that produces chronic symptoms | 2 | [
"pulmonary",
"disease",
",",
"(",
"e.g.",
",",
"restrictive",
"pulmonary",
"disease",
",",
"constrictive",
"or",
"COPD",
")",
"or",
"any",
"other",
"disease",
"or",
"malfunction",
"of",
"the",
"lungs",
"or",
"respiratory",
"system",
"that",
"produces",
"chroni... | [
2,
2,
0,
0,
0,
0,
2,
2,
2,
0,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02542956 | 45:71:treatment | Participating in another study involving an investigational medication | 2 | [
"Participating",
"in",
"another",
"study",
"involving",
"an",
"investigational",
"medication"
] | [
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02836899 | 1:24:chronic_disease,, | Hemodynamic instability as defined by a systolic blood pressure <90 mmHg | 2 | [
"Hemodynamic",
"instability",
"as",
"defined",
"by",
"a",
"systolic",
"blood",
"pressure",
"<",
"90",
"mmHg"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02526212 | 21:24:treatment | Currently receiving BMT at Montefiore community health center (CHC) | 2 | [
"Currently",
"receiving",
"BMT",
"at",
"Montefiore",
"community",
"health",
"center",
"(",
"CHC",
")"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03181516 | 1:13:treatment | Erythromycin | 2 | [
"Erythromycin"
] | [
1
] |
NCT02490631 | 1:9:chronic_disease | Diabetic | 2 | [
"Diabetic"
] | [
2
] |
NCT02308202 | 29:33:chronic_disease | Meet DSM-IV TR criteria for PTSD | 2 | [
"Meet",
"DSM-IV",
"TR",
"criteria",
"for",
"PTSD"
] | [
0,
0,
0,
0,
0,
2
] |
NCT02934555 | 1:15:chronic_disease | Cardiac arrest defined by cessation of pulse requiring chest compressions | 2 | [
"Cardiac",
"arrest",
"defined",
"by",
"cessation",
"of",
"pulse",
"requiring",
"chest",
"compressions"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02931110 | ,10:21:chronic_disease | Grade ≥2 bradycardia | 2 | [
"Grade",
"≥2",
"bradycardia"
] | [
0,
0,
2
] |
NCT02584244 | ,82:101:chronic_disease | total bilirubin within normal institutional limits (except in cases of malignant biliary obstruction) | 2 | [
"total",
"bilirubin",
"within",
"normal",
"institutional",
"limits",
"(",
"except",
"in",
"cases",
"of",
"malignant",
"biliary",
"obstruction",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0
] |
NCT00788164 | 1:25:cancer | nonmelanoma skin lesions | 2 | [
"nonmelanoma",
"skin",
"lesions"
] | [
3,
3,
3
] |
NCT01989585 | 1:16:treatment,18:31:treatment,33:46:treatment,48:61:treatment,63:72:treatment,76:87:treatment | Anticonvulsants: carbamazepine, oxcarbazepine, phenobarbital, phenytoin, s-mephenytoin | 2 | [
"Anticonvulsants",
":",
"carbamazepine",
",",
"oxcarbazepine",
",",
"phenobarbital",
",",
"phenytoin",
",",
"s-mephenytoin"
] | [
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1
] |
NCT02332850 | 14:16:cancer,38:60:treatment,66:86:treatment | Diagnosis of MM and documentation of treatment with an IMiD® and proteasome inhibitor | 2 | [
"Diagnosis",
"of",
"MM",
"and",
"documentation",
"of",
"treatment",
"with",
"an",
"IMiD®",
"and",
"proteasome",
"inhibitor"
] | [
0,
0,
3,
0,
0,
0,
1,
1,
1,
1,
0,
1,
1
] |
NCT02536170 | 12:20:allergy_name | Allergy to arginine | 2 | [
"Allergy",
"to",
"arginine"
] | [
0,
0,
4
] |
NCT03141359 | 23:38:treatment,98:115:treatment,178:187:treatment,201:211:cancer | Subjects who have had prior radiation to the region of the chest that would result in overlap of radiation therapy fields and determined by the treating physician to impede the treatment of the study malignancy | 2 | [
"Subjects",
"who",
"have",
"had",
"prior",
"radiation",
"to",
"the",
"region",
"of",
"the",
"chest",
"that",
"would",
"result",
"in",
"overlap",
"of",
"radiation",
"therapy",
"fields",
"and",
"determined",
"by",
"the",
"treating",
"physician",
"to",
"impede",
... | [
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
3
] |
NCT02245841 | 1:22:treatment | mycophenolate mofetil | 2 | [
"mycophenolate",
"mofetil"
] | [
1,
1
] |
NCT03176784 | 7:29:treatment | using Chantix or varenicline and not willing to stop for duration of the study | 2 | [
"using",
"Chantix",
"or",
"varenicline",
"and",
"not",
"willing",
"to",
"stop",
"for",
"duration",
"of",
"the",
"study"
] | [
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01175044 | 88:108:chronic_disease | Inability to provide informed consent or to comply with study assessments (e.g. due to cognitive impairment or geographic distance) | 2 | [
"Inability",
"to",
"provide",
"informed",
"consent",
"or",
"to",
"comply",
"with",
"study",
"assessments",
"(",
"e.g",
".",
"due",
"to",
"cognitive",
"impairment",
"or",
"geographic",
"distance",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0
] |
NCT02422641 | 8:17:chronic_disease | Active mucositis | 2 | [
"Active",
"mucositis"
] | [
0,
2
] |
NCT02778282 | 1:33:chronic_disease | Substantial cognitive impairment | 2 | [
"Substantial",
"cognitive",
"impairment"
] | [
2,
2,
2
] |
NCT02362308 | 1:18:chronic_disease | Mental conditions rendering the subject unable to understand the nature, scope and possible consequences of the study | 2 | [
"Mental",
"conditions",
"rendering",
"the",
"subject",
"unable",
"to",
"understand",
"the",
"nature",
",",
"scope",
"and",
"possible",
"consequences",
"of",
"the",
"study"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02408861 | 50:66:allergy_name | delayed-type hypersensitivity reaction caused by contact allergen | 2 | [
"delayed-type",
"hypersensitivity",
"reaction",
"caused",
"by",
"contact",
"allergen"
] | [
0,
0,
0,
0,
0,
4,
4
] |
NCT02635919 | 21:42:treatment | Recently prescribed varenicline (Chantix) with the intention to quit smoking in the next 3 months | 2 | [
"Recently",
"prescribed",
"varenicline",
"(",
"Chantix",
")",
"with",
"the",
"intention",
"to",
"quit",
"smoking",
"in",
"the",
"next",
"3",
"months"
] | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02422641 | 43:65:cancer | Histologically or cytologically confirmed invasive breast cancer | 2 | [
"Histologically",
"or",
"cytologically",
"confirmed",
"invasive",
"breast",
"cancer"
] | [
0,
0,
0,
0,
3,
3,
3
] |
NCT02484300 | 1:34:treatment | Prior or current use of melatonin | 2 | [
"Prior",
"or",
"current",
"use",
"of",
"melatonin"
] | [
1,
1,
1,
1,
1,
1
] |
NCT01436968 | 21:75:treatment | Planning to undergo standard prostate-only external beam radiation therapy | 2 | [
"Planning",
"to",
"undergo",
"standard",
"prostate-only",
"external",
"beam",
"radiation",
"therapy"
] | [
0,
0,
0,
1,
1,
1,
1,
1,
1
] |
NCT02343042 | 24:26:chronic_disease,,,78:97:treatment,105:116:cancer | Documented evidence of PD after achieving at least SD for ≥ 1 cycle during a previous MM regimen (i.e., relapsed MM) | 2 | [
"Documented",
"evidence",
"of",
"PD",
"after",
"achieving",
"at",
"least",
"SD",
"for",
"≥",
"1",
"cycle",
"during",
"a",
"previous",
"MM",
"regimen",
"(",
"i.e.",
",",
"relapsed",
"MM",
")"
] | [
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
3,
3,
0
] |
NCT02712736 | 22:54:chronic_disease | Patients with active inflammatory bowel disease (IBD) flares | 2 | [
"Patients",
"with",
"active",
"inflammatory",
"bowel",
"disease",
"(",
"IBD",
")",
"flares"
] | [
0,
0,
0,
2,
2,
2,
2,
0,
0,
0
] |
NCT01773694 | 25:43:treatment,47:53:cancer,58:75:cancer | patients undergoing any surgical treatment of benign and malignant lesions by any physician in the Dermatology department | 2 | [
"patients",
"undergoing",
"any",
"surgical",
"treatment",
"of",
"benign",
"and",
"malignant",
"lesions",
"by",
"any",
"physician",
"in",
"the",
"Dermatology",
"department"
] | [
0,
0,
0,
1,
1,
0,
3,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02030028 | 28:42:treatment, | Have received at least are biologic agent for at least 6 months | 2 | [
"Have",
"received",
"at",
"least",
"are",
"biologic",
"agent",
"for",
"at",
"least",
"6",
"months"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02938559 | 17:33:chronic_disease,64:74:chronic_disease,102:104:treatment | Evidence of any medical disorder or condition that could cause depression, preclude participation in CT, or is associated with memory problems, that is not currently stabilized and/or managed under the care of a physician | 2 | [
"Evidence",
"of",
"any",
"medical",
"disorder",
"or",
"condition",
"that",
"could",
"cause",
"depression",
",",
"preclude",
"participation",
"in",
"CT",
",",
"or",
"is",
"associated",
"with",
"memory",
"problems",
",",
"that",
"is",
"not",
"currently",
"stabil... | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00409435 | 30:44:treatment, | Patients must not have taken pyridostigmine in the past month | 2 | [
"Patients",
"must",
"not",
"have",
"taken",
"pyridostigmine",
"in",
"the",
"past",
"month"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT01720836 | 41:63:treatment | Subjects may not be receiving any other investigational agents | 2 | [
"Subjects",
"may",
"not",
"be",
"receiving",
"any",
"other",
"investigational",
"agents"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01994538 | 52:55:chronic_disease,73:89:chronic_disease,91:121:chronic_disease | Symptoms thought more likely to be caused by a non-UTI diagnosis (e.g., urinary calculus, sexually transmitted infection, etc.) | 2 | [
"Symptoms",
"thought",
"more",
"likely",
"to",
"be",
"caused",
"by",
"a",
"non-UTI",
"diagnosis",
"(",
"e.g.",
",",
"urinary",
"calculus",
",",
"sexually",
"transmitted",
"infection",
",",
"etc",
".",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0
] |
NCT02314377 | ,,,,,,226:245:treatment, | Patients must not have proteinuria at screening as demonstrated by either 1) urine protein: creatinine (UPC) ratio > 1.0 at screening, OR 2) urine dipstick for proteinuria ≥ 2+ (patients discovered to have ≥2+ proteinuria on dipstick urinalysis at baseline should undergo a 24 hour urine collection and must demonstrate ... | 2 | [
"Patients",
"must",
"not",
"have",
"proteinuria",
"at",
"screening",
"as",
"demonstrated",
"by",
"either",
"1",
")",
"urine",
"protein",
":",
"creatinine",
"(",
"UPC",
")",
"ratio",
">",
"1.0",
"at",
"screening",
",",
"OR",
"2",
")",
"urine",
"dipstick",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT02355002 | 1:17:treatment | vagal stimulator | 2 | [
"vagal",
"stimulator"
] | [
1,
1
] |
NCT02064296 | 22:27:treatment,29:33:treatment,38:52:treatment | Contraindications to fcMRI, fMRI, or 1H-MRS methods | 2 | [
"Contraindications",
"to",
"fcMRI",
",",
"fMRI",
",",
"or",
"1H-MRS",
"methods"
] | [
0,
0,
1,
0,
1,
0,
0,
1,
1
] |
NCT02668744 | 5:13:chronic_disease,15:24:chronic_disease,29:53:chronic_disease | Any physical, cognitive, or psychological disability that would prevent participation in the study | 2 | [
"Any",
"physical",
",",
"cognitive",
",",
"or",
"psychological",
"disability",
"that",
"would",
"prevent",
"participation",
"in",
"the",
"study"
] | [
0,
2,
0,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT03008408 | 12:36:chronic_disease,48:69:chronic_disease,71:86:chronic_disease,88:119:chronic_disease,121:141:chronic_disease,171:183:chronic_disease, | History of acute coronary syndromes (including myocardial infarction, unstable angina, coronary artery bypass grafting, coronary angioplasty, or stenting) or symptomatic pericarditis within 6 months prior to screening | 2 | [
"History",
"of",
"acute",
"coronary",
"syndromes",
"(",
"including",
"myocardial",
"infarction",
",",
"unstable",
"angina",
",",
"coronary",
"artery",
"bypass",
"grafting",
",",
"coronary",
"angioplasty",
",",
"or",
"stenting",
")",
"or",
"symptomatic",
"pericardi... | [
0,
0,
2,
2,
2,
2,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT02021279 | 24:49:chronic_disease,57:68:chronic_disease,70:103:chronic_disease,105:121:chronic_disease,123:137:chronic_disease,139:151:chronic_disease,153:165:chronic_disease,169:191:chronic_disease | Subject has a systemic connective tissue disease (e.g., scleroderma, systemic lupus erythematous (SLE), Marfans syndrome, Ehlers Danhlos, collagenosis, polymyositis or polymyalgia rheumatica) | 2 | [
"Subject",
"has",
"a",
"systemic",
"connective",
"tissue",
"disease",
"(",
"e.g.",
",",
"scleroderma",
",",
"systemic",
"lupus",
"erythematous",
"(",
"SLE",
")",
",",
"Marfans",
"syndrome",
",",
"Ehlers",
"Danhlos",
",",
"collagenosis",
",",
"polymyositis",
"o... | [
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
2,
0,
2,
0,
2,
2,
0
] |
NCT03011801 | 1:26:treatment, | Corticosteroid medication use during this pregnancy | 2 | [
"Corticosteroid",
"medication",
"use",
"during",
"this",
"pregnancy"
] | [
1,
1,
0,
0,
0,
0
] |
NCT03101566 | 27:51:treatment, | Must not have undergone a major surgical procedure < 4 weeks prior to registration | 2 | [
"Must",
"not",
"have",
"undergone",
"a",
"major",
"surgical",
"procedure",
"<",
"4",
"weeks",
"prior",
"to",
"registration"
] | [
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02582827 | ,,17:30:chronic_disease, | Class III or IV heart failure as defined by the New York Heart Association (NYHA) functional classification | 2 | [
"Class",
"III",
"or",
"IV",
"heart",
"failure",
"as",
"defined",
"by",
"the",
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")",
"functional",
"classification"
] | [
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01794793 | 48:75:treatment | Patient has been permanently discontinued from pasireotide study treatment in the parent study due to unacceptable toxicity, non-compliance to study procedures, withdrawal of consent or any other reason | 2 | [
"Patient",
"has",
"been",
"permanently",
"discontinued",
"from",
"pasireotide",
"study",
"treatment",
"in",
"the",
"parent",
"study",
"due",
"to",
"unacceptable",
"toxicity",
",",
"non-compliance",
"to",
"study",
"procedures",
",",
"withdrawal",
"of",
"consent",
"... | [
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02490631 | 1:28:chronic_disease | intradural spinal pathology | 2 | [
"intradural",
"spinal",
"pathology"
] | [
2,
2,
2
] |
NCT01572480 | 12:18:chronic_disease | Absence of anemia | 2 | [
"Absence",
"of",
"anemia"
] | [
0,
0,
2
] |
NCT02349867 | 1:8:chronic_disease,10:23:chronic_disease,28:45:chronic_disease | Medical, psychological, or social conditions | 2 | [
"Medical",
",",
"psychological",
",",
"or",
"social",
"conditions"
] | [
2,
0,
2,
0,
0,
2,
2
] |
NCT01850758 | 92:114:treatment,121:127:treatment,149:165:treatment,, | Pain, swelling, or functional disability in the affected knee with activity, having failed conservative treatment (e.g. NSAIDs, physician initiated physical therapy) for at least 3 months or unable to return to normal day to day activities by 6 weeks | 2 | [
"Pain",
",",
"swelling",
",",
"or",
"functional",
"disability",
"in",
"the",
"affected",
"knee",
"with",
"activity",
",",
"having",
"failed",
"conservative",
"treatment",
"(",
"e.g",
".",
"NSAIDs",
",",
"physician",
"initiated",
"physical",
"therapy",
")",
"fo... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01872975 | 1:21:treatment | Sentinel node biopsy alone | 2 | [
"Sentinel",
"node",
"biopsy",
"alone"
] | [
1,
1,
1,
0
] |
NCT02793921 | 1:17:treatment | wound dehiscence | 2 | [
"wound",
"dehiscence"
] | [
1,
1
] |
NCT02575404 | 4:19:chronic_disease | No active bleeding | 2 | [
"No",
"active",
"bleeding"
] | [
0,
2,
2
] |
NCT02953860 | 5:13:treatment,16:28:treatment,19:28:treatment,40:52:treatment, | two biopsies - pretreatment as regards enzalutamide, and during treatment at 4 weeks | 2 | [
"two",
"biopsies",
"-",
"pretreatment",
"as",
"regards",
"enzalutamide",
",",
"and",
"during",
"treatment",
"at",
"4",
"weeks"
] | [
0,
1,
0,
1,
0,
0,
1,
0,
0,
0,
1,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.